相似文献
1
Clinical significance of serum angiocidin levels in hepatocellular carcinoma.
Cancer Lett. 2007 Jun 18;251(1):28-35. doi: 10.1016/j.canlet.2006.10.023. Epub 2006 Dec 22.
2
[Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
Zhonghua Zhong Liu Za Zhi. 2001 Sep;23(5):389-92.
3
Reduction of angiocidin contributes to decreased HepG2 cell proliferation.
Afr Health Sci. 2013 Sep;13(3):560-4. doi: 10.4314/ahs.v13i3.5.
4
Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
Chin Med J (Engl). 2003 May;116(5):772-6.
5
High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Eur J Surg Oncol. 2013 Oct;39(10):1129-35. doi: 10.1016/j.ejso.2013.06.023. Epub 2013 Jul 31.
6
The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.
J Cancer Res Clin Oncol. 2006 Nov;132(11):709-17. doi: 10.1007/s00432-006-0119-3. Epub 2006 Jun 20.
7
[Expression and clinical significance of nerve growth factor in primary liver cancer].
Zhonghua Gan Zang Bing Za Zhi. 2013 Feb;21(2):121-4. doi: 10.3760/cma.j.issn.1007-3418.2013.02.011.
8
Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging.
Ann Hepatol. 2013 Nov-Dec;12(6):915-25.
9
[Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].
Zhonghua Gan Zang Bing Za Zhi. 2009 Sep;17(9):661-4.
10
A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma.
Cancer. 2012 Aug 15;118(16):3984-92. doi: 10.1002/cncr.26726. Epub 2011 Dec 16.
引用本文的文献
1
Oncofetal MCB1 Is a Functional Biomarker for HCC Personalized Therapy.
Adv Sci (Weinh). 2024 Dec;11(45):e2401228. doi: 10.1002/advs.202401228. Epub 2024 Oct 14.
2
Reduction of angiocidin contributes to decreased HepG2 cell proliferation.
Afr Health Sci. 2013 Sep;13(3):560-4. doi: 10.4314/ahs.v13i3.5.
3
The interaction of angiocidin with tissue transglutaminase.
Exp Mol Pathol. 2010 Feb;88(1):15-25. doi: 10.1016/j.yexmp.2009.11.001. Epub 2009 Nov 18.
4
Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: exploring the functional significance in tumor cell invasion.
Exp Mol Pathol. 2009 Dec;87(3):184-8. doi: 10.1016/j.yexmp.2009.09.002. Epub 2009 Sep 9.
5
The novel angiogenic inhibitor, angiocidin, induces differentiation of monocytes to macrophages.
Cancer Res. 2008 Jul 15;68(14):5905-14. doi: 10.1158/0008-5472.CAN-07-6179.
本文引用的文献
1
Integrin alpha2beta1 mediates the anti-angiogenic and anti-tumor activities of angiocidin, a novel tumor-associated protein.
Exp Cell Res. 2006 Aug 1;312(13):2443-53. doi: 10.1016/j.yexcr.2006.04.009. Epub 2006 Apr 30.
2
Serum tumor markers for detection of hepatocellular carcinoma.
World J Gastroenterol. 2006 Feb 28;12(8):1175-81. doi: 10.3748/wjg.v12.i8.1175.
3
Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma.
Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4150-7. doi: 10.1158/1078-0432.CCR-03-0435.
4
Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1.
J Cell Biochem. 2004 May 1;92(1):125-46. doi: 10.1002/jcb.20076.
5
Treatment of hepatocellular carcinoma: is there an optimal strategy?
Cancer Treat Rev. 2003 Apr;29(2):99-104. doi: 10.1016/s0305-7372(02)00123-8.
6
Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features.
Cancer. 2002 Nov 1;95(9):1931-7. doi: 10.1002/cncr.10892.
7
Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas.
Biochim Biophys Acta. 2001 Apr 30;1536(1):1-12. doi: 10.1016/s0925-4439(01)00026-6.
8
The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer.
Histol Histopathol. 2001 Apr;16(2):345-51. doi: 10.14670/HH-16.345.
9
Characterization of two polyubiquitin binding sites in the 26 S protease subunit 5a.
J Biol Chem. 1998 Mar 6;273(10):5461-7. doi: 10.1074/jbc.273.10.5461.
10
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.
Cell. 1997 Jan 24;88(2):277-85. doi: 10.1016/s0092-8674(00)81848-6.
Zotero 插件